amsbiowp, Author at AMSbiopharma

UPLC-MS/MS method submissions for peptides

Implementation of UPLC‑MS/MS workflows in peptide therapeutics: from method development to regulatory submission

Peptide therapeutics represent a rapidly growing segment of pharmaceutical pipelines, offering high specificity and potency. However, their bioanalysis poses unique challenges due to low concentration in complex biological matrices and structural instability. To overcome these hurdles, the industry is increasingly…

peptide stability requires specialized analytical methods

Analytical method development and stability-indicating strategies for synthetic peptide therapeutics under ICH regulatory frameworks

The pharmaceutical landscape is increasingly dominated by peptide therapeutics, which offer higher specificity and efficacy than small molecules. However, their complex chemical structures and inherent susceptibility to degradation present unique challenges in quality control. The transition of a synthetic peptide…

Challenges in Preclinical Research Partnerships

Preclinical Contract Research to Accelerate Drug Development: Study Design and FDA Toxicology Guidelines Considerations

Before a drug candidate reaches clinical testing, it must demonstrate safety and efficacy under controlled laboratory conditions. This early work, known as preclinical research, establishes whether a compound has a reasonable likelihood of success in humans. The quality and rigor…

Optimizing LC‑MS/MS Sensitivity: Strategies to Overcome Ion Suppression and Boost Robustness in Bioanalysis

Liquid chromatography coupled with tandem mass spectrometry (LC‑MS/MS) has become the reference technique for quantitative bioanalysis in drug development, pharmacokinetics, toxicology studies, and biomarker research. As regulatory expectations for sensitivity and reproducibility rise, laboratories increasingly turn to LC‑MS/MS to quantify…

Biomarkers Empower Bioanalytical Research

Application of Biomarkers in Bioanalytics: Enabling Translational Development in Pharmaceutical R&D

In bioanalytical workflows, biomarkers serve as quantifiable proxies for biological processes, disease states, or therapeutic responses. Still, the rapid evolution of drug discovery and clinical development has transformed biomarkers from useful indicators into critical decision-making tools. Their application spans every…

Mass Spectrometry in GMP Environments in Drug Development

Mass Spectrometry in GMP Environments: Enhancing QC and Compliance in Drug Development

In today’s highly regulated biopharmaceutical landscape, ensuring quality, safety, and efficacy across the drug development lifecycle is both a scientific imperative and a regulatory mandate. As therapies become more complex, traditional analytical tools are often challenged by demands for higher…

AMSbiopharma completes its Innovation Plan, supported by Innova Pyme, achieving progress in services, technology, and entrepreneurial culture

AMSbiopharma presented today, in an online event, the results of its Innovation Plan, developed over the past 18 months with the support of the Galician Innovation Agency (GAIN) through the Innova Pyme 2024 program. This initiative strengthens the company’s competitive…

Impurity Profiling in Pharmaceuticals: Analytical Methods and Compliance

Ensuring the safety, efficacy, and quality of pharmaceutical products requires a thorough understanding of the impurities that may be present throughout the development and manufacturing process. These impurities, even at trace levels, can compromise therapeutic performance or pose risks to…

Pharmacokinetics and Pharmacodynamics (PK/PD) Studies in Drug Development: From ADME Principles to Translational Applications

Understanding how a drug behaves in the body and how it exerts its therapeutic effects is essential for developing safe and effective treatments. From early discovery to regulatory approval, pharmacokinetics (PK) and pharmacodynamics (PD) are core disciplines that help characterize…

Quality Control and Regulatory Compliance

Pharma Quality Control Strategies for Drug Development and Regulatory Compliance

In pharmaceutical development, ensuring that products consistently meet predefined standards of identity, strength, purity, and quality it’s essential. As drug candidates move from early research through commercial production, robust pharma quality control strategies become the backbone of safe, effective, and…

Implementation of UPLC‑MS/MS workflows in peptide therapeutics: from method development to regulatory submission

Analytical method development and stability-indicating strategies for synthetic peptide therapeutics under ICH regulatory frameworks

Preclinical Contract Research to Accelerate Drug Development: Study Design and FDA Toxicology Guidelines Considerations

Optimizing LC‑MS/MS Sensitivity: Strategies to Overcome Ion Suppression and Boost Robustness in Bioanalysis

Application of Biomarkers in Bioanalytics: Enabling Translational Development in Pharmaceutical R&D

Mass Spectrometry in GMP Environments: Enhancing QC and Compliance in Drug Development

AMSbiopharma completes its Innovation Plan, supported by Innova Pyme, achieving progress in services, technology, and entrepreneurial culture

Impurity Profiling in Pharmaceuticals: Analytical Methods and Compliance

Pharmacokinetics and Pharmacodynamics (PK/PD) Studies in Drug Development: From ADME Principles to Translational Applications

Pharma Quality Control Strategies for Drug Development and Regulatory Compliance

Contact us

Subscribe to our newsletter